Market Research Report Store OncoTherapy Science Inc (4564) – Pharmaceuticals & | Page 4

OncoTherapy Science Inc, Medical Devices Deals, 2011 to YTD 2017
9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details
Partnerships
10
11
11
OncoTherapy Science and Tella Enter into Co-Development Agreement
11
OncoTherapy Science Enters Into Co-Development Agreement With Acronet
Licensing Agreements
11
12
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines
12
Ono Pharma Enters Into Licensing Agreement With OncoTherapy
Equity Offering
13
14
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million
OncoTherapy Science Inc - Key Competitors
Key Employees
14
15
16
Locations And Subsidiaries 17
Head Office
17
Other Locations & Subsidiaries
Recent Developments
Product News
17
18
18
Apr 22, 2016: OncoTherapy Science: Announcement of “Cancer Precision Medicine”
18
02/29/2016: Publication of a paper describing the possible effect of a MELK inhibitor OTS167 on
kidney cancer
19
02/29/2016: Publication of a paper describing the possible effect of a TOPK inhibitor OTS514
02/26/2016: Publication for possible biomarkers of OTS167, MELK inhibitor
21
20